Research indicates that Pso has strong connections to metabolic syndrome and insulin resistance, while GLP-1RAs might provide anti-inflammatory benefits through the TNF-α and IL-17 pathways [8,62]. This evidence concerns the gene IL17A and Insulin resistance.